ClearPoint Neuro (CLPT) Debt Ratio (2011 - 2026)
ClearPoint Neuro recorded quarterly Debt Ratio of 0.53 in Q1 2026, up 5.85% quarter-over-quarter from 0.5 in Q4 2025.
ClearPoint Neuro's Debt Ratio history runs 15 years deep, the most recent figure standing at 0.53 for Q1 2026.
- In Q1 2026, Debt Ratio changed N/A year-over-year to 0.53; the TTM figure through Mar 2026 stood at 0.53 (changed N/A YoY), while the FY2025 annual figure was 0.5, changed N/A from the prior year.
- Debt Ratio came in at 0.53 for Q1 2026 at ClearPoint Neuro, up from 0.5 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.53 in Q1 2026 to a low of 0.16 in Q1 2022.
- A 4-year average of 0.29 and a median of 0.22 in 2023 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio tumbled 51.69% in 2022 and surged 32.46% in 2023, its largest moves.
- ClearPoint Neuro's Debt Ratio stood at 0.18 in 2022, then surged by 30.81% to 0.23 in 2023, then soared by 115.29% to 0.5 in 2025, then climbed by 5.85% to 0.53 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.53, 0.5, and 0.48 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.53 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.46 |
| Dec 31, 2023 | 0.23 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | 0.20 |
| Dec 31, 2022 | 0.18 |
| Sep 30, 2022 | 0.17 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.26 |
| Jun 30, 2021 | 0.24 |
| Mar 31, 2021 | 0.33 |
| Dec 31, 2020 | 0.85 |
| Sep 30, 2020 | 0.04 |
| Jun 30, 2020 | 0.04 |
| Mar 31, 2020 | 0.74 |
| Dec 31, 2019 | 0.17 |
| Sep 30, 2019 | 0.14 |
| Jun 30, 2019 | 0.14 |
| Mar 31, 2019 | 0.26 |
| Dec 31, 2018 | 0.25 |
| Sep 30, 2018 | 0.22 |
| Jun 30, 2018 | 0.11 |
| Mar 31, 2018 | 0.10 |
| Dec 31, 2017 | 0.14 |
| Dec 31, 2016 | 0.29 |
| Sep 30, 2016 | 0.27 |
| Jun 30, 2016 | 0.48 |
| Mar 31, 2016 | 0.58 |
| Dec 31, 2015 | 0.11 |
| Sep 30, 2015 | 0.26 |
| Jun 30, 2015 | 0.57 |
| Mar 31, 2015 | 0.66 |
| Dec 31, 2014 | 0.46 |
| Sep 30, 2014 | 1.10 |
| Jun 30, 2014 | 0.75 |
| Mar 31, 2014 | 0.71 |
| Dec 31, 2013 | 0.97 |
| Sep 30, 2013 | 0.45 |
| Jun 30, 2013 | 0.60 |
| Mar 31, 2013 | 0.58 |
| Dec 31, 2012 | 0.74 |
| Sep 30, 2012 | 0.51 |
| Jun 30, 2012 | 0.05 |
| Mar 31, 2012 | 0.05 |
| Dec 31, 2011 | 0.06 |